Literature DB >> 12634979

Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men.

E F L Dubois1, M G M Derks, A H Zwinderman, P N R Dekhuijzen, C J Van Boxtel, D H Schweitzer.   

Abstract

OBJECTIVE: To study the effects of prednisolone (PRED) and dexamethasone (DEXA) in assumed clinically equivalent doses towards the lowering of cortisol, osteocalcin (OC) and the stimulated rise of eosinophilic cationic protein (ECP) by granulocyte colony stimulating factor (G-CSF).
METHODS: At four separate sessions of 25 h each, saline i.v. alone, G-CSF s.c. alone or in combination with either 12.5 mg PRED i.v. or 2.0 mg DEXA i.v., were randomly administered in eight healthy male subjects.
RESULTS: All subjects had equal lowering of cortisol after DEXA and PRED at 10 h, whereas a sustained suppression at 25 h persisted only after administration of DEXA. Between 4 h and 10 h after administration of DEXA and PRED, the change in the area under the concentration-time curve (DeltaAUC4-10) of OC became 24.4% and 2.3% lower, respectively ( p<0.0001). After 25 h, this effect persisted for DEXA. DeltaAUC4-10 of the G-CSF-stimulated ECP response decreased by a mean of 76.8% after PRED compared with DEXA and to controls ( p<0.02), and this difference had disappeared at 25 h. DEXA did not elicit any effect towards the G-CSF-stimulated ECP response.
CONCLUSION: PRED and DEXA in formerly assumed clinically equivalent doses induced a similar suppression towards cortisol within the first 10 h, but had different actions towards blood concentrations of OC and ECP following G-CSF stimulation in healthy male subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634979     DOI: 10.1007/s00228-002-0549-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Corticosteroid pharmacodynamic modeling: osteocalcin suppression by prednisolone.

Authors:  J A Wald; W J Jusko
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

Review 2.  Inflammatory mediators of asthma: an update.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  Pharmacol Rev       Date:  1998-12       Impact factor: 25.468

3.  The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.

Authors:  A M Wever; J Wever-Hess; J Hermans
Journal:  Clin Exp Allergy       Date:  1997-05       Impact factor: 5.018

4.  Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects.

Authors:  G Babadjanova; B Allolio; M Vollmer; M Reincke; H M Schulte
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

5.  Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins.

Authors:  M Karawajczyk; M Höglund; J Ericsson; P Venge
Journal:  Br J Haematol       Date:  1997-02       Impact factor: 6.998

6.  Eosinophil cationic protein in serum from nonatopic and asymptomatic atopic individuals after standardized blood clotting at 37 degrees C.

Authors:  C J Pronk-Admiraal; P C Bartels; K Mulder
Journal:  Ann Clin Biochem       Date:  1999-05       Impact factor: 2.057

7.  A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort.

Authors:  V LoCascio; P Ballanti; S Milani; F Bertoldo; C LoCascio; E M Zanolin; E Bonucci
Journal:  Calcif Tissue Int       Date:  1998-03       Impact factor: 4.333

8.  The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects.

Authors:  H K Nielsen; P Charles; L Mosekilde
Journal:  J Clin Endocrinol Metab       Date:  1988-11       Impact factor: 5.958

9.  Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland.

Authors:  P L Toutain; R A Brandon; H de Pomyers; M Alvinerie; J D Baggot
Journal:  Am J Vet Res       Date:  1984-09       Impact factor: 1.156

10.  Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo.

Authors:  C G Peterson; I Enander; J Nystrand; A S Anderson; L Nilsson; P Venge
Journal:  Clin Exp Allergy       Date:  1991-09       Impact factor: 5.018

View more
  3 in total

1.  Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.

Authors:  Dario Caronzolo; Valeria Lucini; Marilou Pannacci; Silvia Grosso; Federica Colleoni; Franco Fraschini; Francesco Scaglione
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.

Authors:  E F L Dubois; M G M Derks; D H Schweitzer; A H Zwinderman; P N R Dekhuijzen; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  2004-05-19       Impact factor: 2.953

Review 3.  Drug-metabolizing enzymes CYP3A as a link between tacrolimus and vitamin D in renal transplant recipients: is it relevant in clinical practice?

Authors:  Agnieszka Prytuła; Karlien Cransberg; Ann Raes
Journal:  Pediatr Nephrol       Date:  2018-07-30       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.